
Please try another search
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S was incorporated in 1997 and is based in Søborg, Denmark.
Name | Age | Since | Title |
---|---|---|---|
Tanja Erichsen | - | 2024 | Alternate Director |
Kirsten Aarup Drejer | 68 | 2018 | Independent Vice Chairman |
Jeffrey Berkowitz | 58 | 2019 | Independent Director |
Elaine Sullivan | 63 | 2023 | Director & Member of Advisory Board |
Cecilie Kold | - | - | Alternate Director |
Katja Hansen | - | 2024 | Alternate Director |
Adam Nygaard | - | 2024 | Employee Representative |
Lars Pedersen | - | 2024 | Alternate Director |
Anneline Nansen | 55 | 2021 | Employee Representative Director |
Ludovic Otterbein | - | 2024 | Employee Representative |
Enrique A. Conterno Martinelli | 58 | 2023 | Member of Advisory Board & Director |
Gert Van Assche | - | 2011 | Member of Advisory Board |
Leonard Kruimer | 66 | 2019 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review